>_ QFI Terminal
TerminalStocks › ACHV

Achieve Life Sciences, Inc. (ACHV) Stock

Healthcare · Biotechnology · CA
$4.95 +2.91%
Last updated Sep 20, 2026 15:00 UTC

ACHV Key Statistics

Market Cap$263.54M
P/E (TTM)-3.81
P/S (TTM)
P/B (TTM)12.26
Revenue (TTM)$0.00
EPS (TTM)$-1.30
Dividend Yield
ROE (TTM)-204.14%
Net Margin0.00%
Gross Margin0.00%
52W High$5.25
52W Low$2.62
Analyst ViewBuy
Price Target$4.75
Employees25
Volume67,751

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

CEO: Richard A. Stewart. Company website

ACHV — Frequently Asked Questions

What is the ACHV stock price today?

Achieve Life Sciences, Inc. (ACHV) trades at $4.95, up 2.91% on the day, as of Sep 20, 2026 15:00 UTC.

What is Achieve Life Sciences, Inc.'s market cap?

Achieve Life Sciences, Inc. has a market capitalisation of $263.54M, calculated from the live ACHV share price and shares outstanding.

What is the P/E ratio of ACHV?

ACHV has no meaningful price-to-earnings ratio: Achieve Life Sciences, Inc. lost $1.30 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Achieve Life Sciences, Inc. make?

Achieve Life Sciences, Inc. generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for ACHV?

ACHV has traded between $2.62 and $5.25 over the past 52 weeks, and the last price is 5.7% below that high.

Is Achieve Life Sciences, Inc. profitable?

Yes. Achieve Life Sciences, Inc. keeps 0.00% of revenue as net income over the trailing twelve months.

What is the analyst price target for ACHV?

Wall Street analysts rate ACHV Buy, with an average price target of $4.75, 4.0% below the current price.

What sector is Achieve Life Sciences, Inc. in?

Achieve Life Sciences, Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in CA .

Who is the CEO of Achieve Life Sciences, Inc.?

Richard A. Stewart is the chief executive of Achieve Life Sciences, Inc., which employs 25 people.

Where can I track ACHV in real time?

QFI Terminal shows ACHV with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See ACHV live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open ACHV in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG ARGX argenx SE INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc GMAB Genmab A/S

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.